MedPath

Efficacy of Unilateral Spinal Anaesthesia using very low drugs and administering drug very slowly.

Recruiting
Conditions
American Society of Anaesthesiology physical status Grade 1 and 2
Registration Number
CTRI/2018/03/012819
Lead Sponsor
Leena H Parate
Brief Summary

This is a prospective study to assess



| |

| --- |

|This is a prospective study to assess Unilateral spinal anaesthesia with 6mg of 0.5% (Hyperbaric) bupivacaine and 90mcg of buprenorphine using low dose- slow injection technique in ASA Class 1,2 adults aged 18 years to 65 years undergoing unilateral lower limb surgeries.

The primary outcome is assessment of successful unilateral spinal anaesthesia with 1.2 ml (6mg) of 0.5% (Hyperbaric) Bupivacaine and 90 mcg Buprenorphine using low dose- slow flow technique.

The secondary outcome is to monitor fluctuation in cardiovascular parameters (Blood Pressure, Heart Rate) before and after block,To monitor post-operative micturition time,To notice episode of post-operative nausea and vomiting,Requirement of Atropine and ephedrine intra-operatively.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
79
Inclusion Criteria

ASA grade 1,2 Lower limb surgeries.

Exclusion Criteria

Patients with Autonomic neuropathy Patients with urinary catheter in situ Patients with Vascular pathology Patient on Anticoagulant Patients with Scoliosis Patients with history of Spinal surgeries Pregnancy Severe obese patient (BMI>35Kg/m2).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of Unilateral spinal anaesthesia with 6mg of 0.5% (Hyperbaric) bupivacaine and 90mcg of buprenorphin.20 minutes after spinal anaesthesia
Secondary Outcome Measures
NameTimeMethod
To monitor fluctuation in cardiovascular parameters (Blood Pressure, Heart Rate) before and after block, Monitor post-operative micturition time, Notice episode of post-operative nausea and vomiting, Requirement of Atropine and ephedrine intra-operatively.

Trial Locations

Locations (1)

M.S.Ramaiah Hospital

🇮🇳

Bangalore, KARNATAKA, India

M.S.Ramaiah Hospital
🇮🇳Bangalore, KARNATAKA, India
Dr Rahul Singh
Principal investigator
9953333899
drrahulsingh@outlook.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.